William Plovanic
Stock Analyst at Canaccord Genuity
(3.57)
# 878
Out of 5,041 analysts
151
Total ratings
48.89%
Success rate
5.84%
Average return
Main Sectors:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $132 | $102.11 | +29.27% | 12 | Oct 23, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $142 | $132.74 | +6.98% | 7 | Oct 14, 2025 | |
| ANGO AngioDynamics | Maintains: Buy | $17 → $18 | $12.34 | +45.87% | 8 | Oct 3, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $24 | $15.07 | +59.26% | 6 | Sep 29, 2025 | |
| DXCM DexCom | Maintains: Buy | $106 | $71.56 | +48.13% | 8 | Sep 29, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $170 → $193 | $182.70 | +5.64% | 12 | Sep 29, 2025 | |
| AORT Artivion | Maintains: Buy | $41 → $50 | $43.44 | +15.10% | 3 | Sep 29, 2025 | |
| PODD Insulet | Maintains: Buy | $353 → $399 | $326.03 | +22.38% | 5 | Sep 29, 2025 | |
| HTFL HeartFlow | Maintains: Buy | $35 → $39 | $41.00 | -4.88% | 2 | Sep 22, 2025 | |
| STIM Neuronetics | Maintains: Buy | $8 → $7 | $3.11 | +125.08% | 4 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $75 → $81 | $76.89 | +5.35% | 27 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $97 → $90 | $62.91 | +43.06% | 4 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $115 → $101 | $103.21 | -2.14% | 3 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $18 | $10.19 | +76.64% | 8 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 | $5.15 | +113.59% | 4 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $52 | $37.50 | +38.67% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $12.94 | +155.02% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $7.10 | +111.27% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $254.11 | +11.76% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $16.15 | +54.80% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $1.61 | +647.66% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $83.85 | -16.51% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $27.04 | +77.51% | 5 | Aug 3, 2023 |
Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $132
Current: $102.11
Upside: +29.27%
TransMedics Group
Oct 14, 2025
Maintains: Buy
Price Target: $142
Current: $132.74
Upside: +6.98%
AngioDynamics
Oct 3, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $12.34
Upside: +45.87%
Tandem Diabetes Care
Sep 29, 2025
Maintains: Buy
Price Target: $24
Current: $15.07
Upside: +59.26%
DexCom
Sep 29, 2025
Maintains: Buy
Price Target: $106
Current: $71.56
Upside: +48.13%
iRhythm Technologies
Sep 29, 2025
Maintains: Buy
Price Target: $170 → $193
Current: $182.70
Upside: +5.64%
Artivion
Sep 29, 2025
Maintains: Buy
Price Target: $41 → $50
Current: $43.44
Upside: +15.10%
Insulet
Sep 29, 2025
Maintains: Buy
Price Target: $353 → $399
Current: $326.03
Upside: +22.38%
HeartFlow
Sep 22, 2025
Maintains: Buy
Price Target: $35 → $39
Current: $41.00
Upside: -4.88%
Neuronetics
Aug 6, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.11
Upside: +125.08%
Jul 25, 2025
Maintains: Hold
Price Target: $75 → $81
Current: $76.89
Upside: +5.35%
Jul 22, 2025
Maintains: Buy
Price Target: $97 → $90
Current: $62.91
Upside: +43.06%
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $103.21
Upside: -2.14%
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $10.19
Upside: +76.64%
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $5.15
Upside: +113.59%
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $37.50
Upside: +38.67%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $12.94
Upside: +155.02%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $7.10
Upside: +111.27%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $254.11
Upside: +11.76%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $16.15
Upside: +54.80%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $1.61
Upside: +647.66%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $83.85
Upside: -16.51%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $27.04
Upside: +77.51%